Old Web
English
Sign In
Acemap
>
Paper
>
P1.01-106 Pembrolizumab Randomized, Phase 1 Study in Chinese Patients with Advanced NSCLC: KEYNOTE-032
P1.01-106 Pembrolizumab Randomized, Phase 1 Study in Chinese Patients with Advanced NSCLC: KEYNOTE-032
2018
Yu Xiang Ma
W. Fang
S Xie
Jieying Ge
Huaqiang Zhou
L. Zhang
Keywords:
General surgery
Pembrolizumab
Oncology
Internal medicine
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]